Genprex Inc (GNPX)

Genprex (GNPX) Stock Price & Analysis


GNPX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.19 - $1.94
Previous Close$0.23
Average Volume (3M)293.22K
Market Cap
Enterprise Value$1.96M
Total Cash (Recent Filing)$11.71M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.4
Aug 13, 2019
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.61
Shares Outstanding59,434,822
10 Day Avg. Volume230,879
30 Day Avg. Volume293,218
Standard Deviation0.66
Financial Highlights & Ratios
Price to Book (P/B)1.18
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.08
Enterprise Value/Ebitda-0.38
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Ownership Overview

3.80% Mutual Funds
8.53% Other Institutional Investors
87.67% Public Companies and
Individual Investors


What was Genprex Inc’s price range in the past 12 months?
Genprex Inc lowest stock price was $0.19 and its highest was $1.94 in the past 12 months.
    What is Genprex Inc’s market cap?
    Currently, no data Available
    When is Genprex Inc’s upcoming earnings report date?
    Genprex Inc’s upcoming earnings report date is Aug 13, 2019 which is 1580 days ago.
      How were Genprex Inc’s earnings last quarter?
      Genprex Inc released its earnings results on May 15, 2019. The company reported -$0.141 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.141.
        Is Genprex Inc overvalued?
        According to Wall Street analysts Genprex Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Genprex Inc pay dividends?
          Genprex Inc does not currently pay dividends.
          What is Genprex Inc’s EPS estimate?
          Genprex Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Genprex Inc have?
          Genprex Inc has 59,434,822 shares outstanding.
            What happened to Genprex Inc’s price movement after its last earnings report?
            Genprex Inc reported an EPS of -$0.141 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Genprex Inc?
              Currently, no hedge funds are holding shares in GNPX


              Company Description

              Genprex Inc

              Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.


              Top 5 ETFs holding GNPX

              Market Value
              Smart Score
              Vanguard Total Stock Market ETF
              Up to five ETFs with an Outperform Smart Score that hold GNPX. The ETFs are listed according to market value of GNPX within the ETF

              Forecast EPS vs Actual EPS

              Similar Stocks
              Price & Change
              Cidara Therapeutics

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis